Seiji Itano
Kurashiki, 7010192, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Proteinuria reduction as a surrogate endpoint for clinical study of IgA nephropathy in Japanese patients: data from the J-CKD-DB-Ex.
Journal: Clinical and experimental nephrology
Published: October 02, 2025
Association between early proteinuria reduction and kidney outcomes in Japanese patients with IgA nephropathy: The Japan Chronic Kidney Disease Database.
Journal: Clinical and experimental nephrology
Published: September 16, 2025
Assessment and treatment of metabolic acidosis in CKD: a registry-based study.
Journal: Scientific reports
Published: July 25, 2025
Efficacy of a mobile health application on self-management among Japanese patients with chronic kidney disease.
Journal: Clinical and experimental nephrology
Published: January 27, 2025
ASK-1 activation exacerbates kidney dysfunction via increment of glomerular permeability and accelerates cellular aging in diabetic kidney disease model mice.
Journal: Scientific reports
Published: August 21, 2024
Guidelines for clinical evaluation of chronic kidney disease in early stages : AMED research on regulatory science of pharmaceuticals and medical devices.
Journal: Clinical and experimental nephrology
Published: March 15, 2024
A case series of Fabry diseases with CKD in Japan.
Journal: Clinical and experimental nephrology
Published: September 19, 2023
eGFR slope as a surrogate endpoint for clinical study in early stage of chronic kidney disease: from The Japan Chronic Kidney Disease Database.
Journal: Clinical and experimental nephrology
Published: March 28, 2023
A case of pleuroperitoneal communication during long-term steroid therapy for dermatomyositis.
Journal: Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis
Published: March 23, 2022
Laxative use and mortality in patients on haemodialysis: a prospective cohort study.
Journal: BMC nephrology
Published: May 27, 2021
Kidney Outcomes Associated With SGLT2 Inhibitors Versus Other Glucose-Lowering Drugs in Real-world Clinical Practice: The Japan Chronic Kidney Disease Database.
Journal: Diabetes care
Published: May 19, 2021
Last Updated: 09/26/2026